Global Non-opioid Analgesic Patch Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Non-opioid Analgesic Patch market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Non-opioid Analgesic Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Non-opioid Analgesic Patch include Acorda Therapeutics, Inc, Allergan, Endo International plc, Hisamitsu Pharmaceutical Co.,Inc, IBSA Institut Biochimque SA, Teh Seng Pharmaceutical Mfg, Teikoku Seiyaku Co., Ltd., GlaxoSmithKline Plc and Pfizer, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Non-opioid Analgesic Patch, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Non-opioid Analgesic Patch, also provides the revenue of main regions and countries. Of the upcoming market potential for Non-opioid Analgesic Patch, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-opioid Analgesic Patch revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Non-opioid Analgesic Patch market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Non-opioid Analgesic Patch revenue, projected growth trends, production technology, application and end-user industry.

Non-opioid Analgesic Patch Segment by Company

Acorda Therapeutics, Inc
Allergan
Endo International plc
Hisamitsu Pharmaceutical Co.,Inc
IBSA Institut Biochimque SA
Teh Seng Pharmaceutical Mfg
Teikoku Seiyaku Co., Ltd.
GlaxoSmithKline Plc
Pfizer, Inc.
Mylan N.V.
Non-opioid Analgesic Patch Segment by Type

Capsaicin Patches
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Ketoprofen Patches
Others
Non-opioid Analgesic Patch Segment by Application

Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Non-opioid Analgesic Patch Segment by Region

North America
United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Analgesic Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Analgesic Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Analgesic Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Non-opioid Analgesic Patch in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Non-opioid Analgesic Patch company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-opioid Analgesic Patch revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Non-opioid Analgesic Patch Market by Type
1.2.1 Global Non-opioid Analgesic Patch Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Capsaicin Patches
1.2.3 Lidocaine Patches
1.2.4 Diclofenac Patches
1.2.5 Methyl Salicylate Patches
1.2.6 Ketoprofen Patches
1.2.7 Others
1.3 Non-opioid Analgesic Patch Market by Application
1.3.1 Global Non-opioid Analgesic Patch Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Non-opioid Analgesic Patch Market Dynamics
2.1 Non-opioid Analgesic Patch Industry Trends
2.2 Non-opioid Analgesic Patch Industry Drivers
2.3 Non-opioid Analgesic Patch Industry Opportunities and Challenges
2.4 Non-opioid Analgesic Patch Industry Restraints
3 Global Growth Perspective
3.1 Global Non-opioid Analgesic Patch Market Perspective (2020-2031)
3.2 Global Non-opioid Analgesic Patch Growth Trends by Region
3.2.1 Global Non-opioid Analgesic Patch Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Non-opioid Analgesic Patch Market Size by Region (2020-2025)
3.2.3 Global Non-opioid Analgesic Patch Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Non-opioid Analgesic Patch Revenue by Players
4.1.1 Global Non-opioid Analgesic Patch Revenue by Players (2020-2025)
4.1.2 Global Non-opioid Analgesic Patch Revenue Market Share by Players (2020-2025)
4.1.3 Global Non-opioid Analgesic Patch Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Non-opioid Analgesic Patch Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Non-opioid Analgesic Patch Key Players Headquarters & Area Served
4.4 Global Non-opioid Analgesic Patch Players, Product Type & Application
4.5 Global Non-opioid Analgesic Patch Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Non-opioid Analgesic Patch Market CR5 and HHI
4.6.3 2024 Non-opioid Analgesic Patch Tier 1, Tier 2, and Tier 3
5 Non-opioid Analgesic Patch Market Size by Type
5.1 Global Non-opioid Analgesic Patch Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Non-opioid Analgesic Patch Revenue by Type (2020-2031)
5.3 Global Non-opioid Analgesic Patch Revenue Market Share by Type (2020-2031)
6 Non-opioid Analgesic Patch Market Size by Application
6.1 Global Non-opioid Analgesic Patch Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Non-opioid Analgesic Patch Revenue by Application (2020-2031)
6.3 Global Non-opioid Analgesic Patch Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Acorda Therapeutics, Inc
7.1.1 Acorda Therapeutics, Inc Comapny Information
7.1.2 Acorda Therapeutics, Inc Business Overview
7.1.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.1.4 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Portfolio
7.1.5 Acorda Therapeutics, Inc Recent Developments
7.2 Allergan
7.2.1 Allergan Comapny Information
7.2.2 Allergan Business Overview
7.2.3 Allergan Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.2.4 Allergan Non-opioid Analgesic Patch Product Portfolio
7.2.5 Allergan Recent Developments
7.3 Endo International plc
7.3.1 Endo International plc Comapny Information
7.3.2 Endo International plc Business Overview
7.3.3 Endo International plc Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.3.4 Endo International plc Non-opioid Analgesic Patch Product Portfolio
7.3.5 Endo International plc Recent Developments
7.4 Hisamitsu Pharmaceutical Co.,Inc
7.4.1 Hisamitsu Pharmaceutical Co.,Inc Comapny Information
7.4.2 Hisamitsu Pharmaceutical Co.,Inc Business Overview
7.4.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.4.4 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Portfolio
7.4.5 Hisamitsu Pharmaceutical Co.,Inc Recent Developments
7.5 IBSA Institut Biochimque SA
7.5.1 IBSA Institut Biochimque SA Comapny Information
7.5.2 IBSA Institut Biochimque SA Business Overview
7.5.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.5.4 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Portfolio
7.5.5 IBSA Institut Biochimque SA Recent Developments
7.6 Teh Seng Pharmaceutical Mfg
7.6.1 Teh Seng Pharmaceutical Mfg Comapny Information
7.6.2 Teh Seng Pharmaceutical Mfg Business Overview
7.6.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.6.4 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolio
7.6.5 Teh Seng Pharmaceutical Mfg Recent Developments
7.7 Teikoku Seiyaku Co., Ltd.
7.7.1 Teikoku Seiyaku Co., Ltd. Comapny Information
7.7.2 Teikoku Seiyaku Co., Ltd. Business Overview
7.7.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.7.4 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Portfolio
7.7.5 Teikoku Seiyaku Co., Ltd. Recent Developments
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Comapny Information
7.8.2 GlaxoSmithKline Plc Business Overview
7.8.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.8.4 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Portfolio
7.8.5 GlaxoSmithKline Plc Recent Developments
7.9 Pfizer, Inc.
7.9.1 Pfizer, Inc. Comapny Information
7.9.2 Pfizer, Inc. Business Overview
7.9.3 Pfizer, Inc. Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.9.4 Pfizer, Inc. Non-opioid Analgesic Patch Product Portfolio
7.9.5 Pfizer, Inc. Recent Developments
7.10 Mylan N.V.
7.10.1 Mylan N.V. Comapny Information
7.10.2 Mylan N.V. Business Overview
7.10.3 Mylan N.V. Non-opioid Analgesic Patch Revenue and Gross Margin (2020-2025)
7.10.4 Mylan N.V. Non-opioid Analgesic Patch Product Portfolio
7.10.5 Mylan N.V. Recent Developments
8 North America
8.1 North America Non-opioid Analgesic Patch Revenue (2020-2031)
8.2 North America Non-opioid Analgesic Patch Revenue by Type (2020-2031)
8.2.1 North America Non-opioid Analgesic Patch Revenue by Type (2020-2025)
8.2.2 North America Non-opioid Analgesic Patch Revenue by Type (2026-2031)
8.3 North America Non-opioid Analgesic Patch Revenue Share by Type (2020-2031)
8.4 North America Non-opioid Analgesic Patch Revenue by Application (2020-2031)
8.4.1 North America Non-opioid Analgesic Patch Revenue by Application (2020-2025)
8.4.2 North America Non-opioid Analgesic Patch Revenue by Application (2026-2031)
8.5 North America Non-opioid Analgesic Patch Revenue Share by Application (2020-2031)
8.6 North America Non-opioid Analgesic Patch Revenue by Country
8.6.1 North America Non-opioid Analgesic Patch Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Non-opioid Analgesic Patch Revenue by Country (2020-2025)
8.6.3 North America Non-opioid Analgesic Patch Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Non-opioid Analgesic Patch Revenue (2020-2031)
9.2 Europe Non-opioid Analgesic Patch Revenue by Type (2020-2031)
9.2.1 Europe Non-opioid Analgesic Patch Revenue by Type (2020-2025)
9.2.2 Europe Non-opioid Analgesic Patch Revenue by Type (2026-2031)
9.3 Europe Non-opioid Analgesic Patch Revenue Share by Type (2020-2031)
9.4 Europe Non-opioid Analgesic Patch Revenue by Application (2020-2031)
9.4.1 Europe Non-opioid Analgesic Patch Revenue by Application (2020-2025)
9.4.2 Europe Non-opioid Analgesic Patch Revenue by Application (2026-2031)
9.5 Europe Non-opioid Analgesic Patch Revenue Share by Application (2020-2031)
9.6 Europe Non-opioid Analgesic Patch Revenue by Country
9.6.1 Europe Non-opioid Analgesic Patch Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Non-opioid Analgesic Patch Revenue by Country (2020-2025)
9.6.3 Europe Non-opioid Analgesic Patch Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Non-opioid Analgesic Patch Revenue (2020-2031)
10.2 China Non-opioid Analgesic Patch Revenue by Type (2020-2031)
10.2.1 China Non-opioid Analgesic Patch Revenue by Type (2020-2025)
10.2.2 China Non-opioid Analgesic Patch Revenue by Type (2026-2031)
10.3 China Non-opioid Analgesic Patch Revenue Share by Type (2020-2031)
10.4 China Non-opioid Analgesic Patch Revenue by Application (2020-2031)
10.4.1 China Non-opioid Analgesic Patch Revenue by Application (2020-2025)
10.4.2 China Non-opioid Analgesic Patch Revenue by Application (2026-2031)
10.5 China Non-opioid Analgesic Patch Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Non-opioid Analgesic Patch Revenue (2020-2031)
11.2 Asia Non-opioid Analgesic Patch Revenue by Type (2020-2031)
11.2.1 Asia Non-opioid Analgesic Patch Revenue by Type (2020-2025)
11.2.2 Asia Non-opioid Analgesic Patch Revenue by Type (2026-2031)
11.3 Asia Non-opioid Analgesic Patch Revenue Share by Type (2020-2031)
11.4 Asia Non-opioid Analgesic Patch Revenue by Application (2020-2031)
11.4.1 Asia Non-opioid Analgesic Patch Revenue by Application (2020-2025)
11.4.2 Asia Non-opioid Analgesic Patch Revenue by Application (2026-2031)
11.5 Asia Non-opioid Analgesic Patch Revenue Share by Application (2020-2031)
11.6 Asia Non-opioid Analgesic Patch Revenue by Country
11.6.1 Asia Non-opioid Analgesic Patch Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Non-opioid Analgesic Patch Revenue by Country (2020-2025)
11.6.3 Asia Non-opioid Analgesic Patch Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Non-opioid Analgesic Patch Revenue (2020-2031)
12.2 SAMEA Non-opioid Analgesic Patch Revenue by Type (2020-2031)
12.2.1 SAMEA Non-opioid Analgesic Patch Revenue by Type (2020-2025)
12.2.2 SAMEA Non-opioid Analgesic Patch Revenue by Type (2026-2031)
12.3 SAMEA Non-opioid Analgesic Patch Revenue Share by Type (2020-2031)
12.4 SAMEA Non-opioid Analgesic Patch Revenue by Application (2020-2031)
12.4.1 SAMEA Non-opioid Analgesic Patch Revenue by Application (2020-2025)
12.4.2 SAMEA Non-opioid Analgesic Patch Revenue by Application (2026-2031)
12.5 SAMEA Non-opioid Analgesic Patch Revenue Share by Application (2020-2031)
12.6 SAMEA Non-opioid Analgesic Patch Revenue by Country
12.6.1 SAMEA Non-opioid Analgesic Patch Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Non-opioid Analgesic Patch Revenue by Country (2020-2025)
12.6.3 SAMEA Non-opioid Analgesic Patch Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings